Both your scenarios are potential options, but so is
(c) established player in the traditional hearing aid space looking to ensure revenues aren't impacted greatly by disruption from OTC hearing devices, so they buy a ready-to-market product to sell at pharmacies
Takeover?, page-2
Add NUH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.75M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| NUH (ASX) Chart |
Day chart unavailable